day after glp 1 exhaustion Feeling Tired on Semiglutide 👋🏼 Hey there. Can I

BPC-157 has also shown potential in resolving major vessel occlusion disturbances, such as ischemia-reperfusion injury following the Pringle maneuver and Budd-Chiari syndrome

Let us proceed further and understand how this holy grail ingredient helps our skin

Compounded Semaglutide and Tirzepatide: Safety Concerns FDA enforcement discretion policies during drug shortages have allowed compounding pharmacies to prepare semaglutide and tirzepatide products when commercial supplies were insufficient

Higher dose exploration (4.5mg trials) Rationale for testing 4.5mg: Investigate maximum tolerable dose Determine if higher = better weight loss Establish safety ceiling Results at 4.5mg weekly: Weight loss: ~12% (vs 10% at 2.4mg) Incremental benefit: Only 2% additional loss Side effects: Significantly worse nausea/vomiting Dropout rate: Higher than 2.4mg Clinical verdict: 4.5mg not recommended for routine use Risk-benefit ratio unfavorable 2.4mg remains optimal Some individuals may tolerate 3.0mg as compromise CagriSema combination dosing trials REDEFINE-1 protocol: Semaglutide: 2.4mg weekly (standard titration over 16 weeks) Cagrilintide: 2.4mg weekly (12-week titration) Both given as separate injections Started simultaneously from week 1 Semaglutide escalation (standard): Weeks 1-4: 0.25mg Weeks 5-8: 0.5mg Weeks 9-12: 1.0mg Weeks 13-16: 1.7mg Week 17+: 2.4mg Cagrilintide escalation (when combined): Weeks 1-4: 0.6mg Weeks 5-8: 1.2mg Weeks 9-12: 1.8mg Week 13+: 2.4mg Results: 15.6% average weight loss (68 weeks) Superior to either alone Side effects manageable with slow titration Combination well-tolerated See our cagrilintide and semaglutide combination guide and semaglutide dosage calculator

It can also be paired with BPC-157 for tissue recovery and GHK-Cu in skin rejuvenation and detoxification research

Our Tools 1